Psychedelics Addiction in Louisiana

• PCP and ketamine can cause short-term psychosis, and psychedelics may trigger schizophrenia-like illness in people with predisposing factors.
• Louisiana’s Act 956 funds psychedelic therapy research but doesn’t legalize any substance.
• Ketamine used outside a clinical setting can lead to cravings and withdrawal symptoms, and the DSM-5 recognizes PCP use disorder as a diagnosis.

Lake Detox is an outpatient addiction treatment provider offering Intensive Outpatient treatment for psychedelics addiction in Louisiana.

Psychedelic and dissociative drugs are often described as safer than other drugs. The reality is less comforting: effects are hard to predict, fear, panic, and psychosis are possible, and heavy or repeated use can become a pattern that’s hard to break.

The Drugs and Their Risks

Effects depend on dose, potency, and what else is in the body, and contaminants or combinations can add effects the drug wouldn’t cause alone. NIDA reports:

• LSD. In a 1966 study, three of 65 people with pre-existing psychosis who were given LSD had their symptoms persistently worsen for 3 to 8 months.
• Psilocybin (magic mushrooms). Of almost 2,000 people who had a challenging experience taking it outside a medical setting, 11% said they had put themselves or others at risk of harm.
• MDMA. Some consider it to have psychedelic properties, and limited research suggests it may be associated with mild or moderate heart valve disease.
• Ketamine. Long-term use may cause ketamine-induced uropathy, a treatable but potentially serious urinary condition.
• PCP. NIDA links it to a small number of deaths, typically involving very high doses or combinations of drugs, particularly with alcohol.

What Psychedelics Addiction Looks Like

Whether these drugs are addictive depends on the drug, and “not typically addictive” has never meant safe. Limited research suggests LSD and psilocybin do not typically lead to addiction, but some evidence suggests tolerance can build quickly, pushing people toward larger doses, and psychological dependence can develop. 

Ketamine and PCP are different. Ketamine used outside a clinical setting can lead to cravings and withdrawal symptoms, and the DSM-5 includes both PCP use disorder and “other hallucinogen use disorder,” defined by continued use despite negative consequences.

Psychosis and Mental Health Dangers

NIDA finds little evidence that psychedelics cause long-term psychiatric problems for most people, but the risk isn’t evenly spread. Some evidence suggests psychedelics might trigger schizophrenia-like illness in people with predisposing factors, and PCP and ketamine can make symptoms worse in people who have schizophrenia and cause short-term psychosis: hallucinations, delusions, and trouble telling what’s real.

The safest-looking studies are the controlled ones: modern research excludes people with diagnosed psychosis or bipolar disorder, and poor mental health outcomes may be more likely outside clinical use, where most people use these drugs. Fear and panic, often called a “bad trip,” are also common.

Where Louisiana’s Psychedelic Law Fits In

SB 43 became Act 956 without the governor’s signature and took effect August 1, 2026. It creates a Psychedelic-Assisted Therapy Initiative focused on opioid use disorder, co-occurring substance use disorders, and treatment-resistant conditions, but it doesn’t legalize any substance.

How Lake Detox Treats Psychedelics Addiction

Lake Detox’s clinical team includes licensed psychiatrists, therapists, nurses, and support professionals. Our Intensive Outpatient Program (IOP) offers 9 to 15 hours of group therapy per week for three to six months, individual counseling, and weekly family involvement, scheduled around work, school, and home. IOP is available in Lafayette, Metairie, and Lake Charles.

If psychedelic use is mixed with alcohol, opioids, or benzodiazepines, the assessment may point to Medical Stabilization first, currently offered at the Metairie location only. Treatment isn’t a substitute for emergency care during a psychotic episode.